Cardiovascular Devices Market Research Report Information By Device Type (Diagnostic & Monitoring And Therapeutic & Surgical Devices), By Application (Cardiac Arrhythmia, Coronary Artery Disease, Heart Failure, And Others), By End User (Hospitals, Specialty Clinics, And Others), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Modality

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE

6.1. Overview

6.2. Diagnostic & Monitoring

6.3. Therapeutic & Surgical Devices

7. GLOBAL CARDIOVASCULAR DEVICES MARKET, BY APPLICATION

7.1. Overview

7.2. Cardiac Arrhythmia

7.3. Coronary Artery Disease

7.4. Heart Failure

7.5. Others

8. GLOBAL CARDIOVASCULAR DEVICES MARKET, BY END USER

8.1. Overview

8.2. Hospitals

8.3. Specialty Clinics

8.4. Others

9. GLOBAL CARDIOVASCULAR DEVICES MARKET, BY REGION

9.1. Overview

9.2. North America

9.2.1. U.S.

9.2.2. Canada

9.3. Europe

9.3.1. Germany

9.3.2. France

9.3.3. U.K

9.3.4. Italy

9.3.5. Spain

9.3.6. Rest of Europe

9.4. Asia-Pacific

9.4.1. China

9.4.2. India

9.4.3. Japan

9.4.4. South Korea

9.4.5. Australia

9.4.6. Rest of Asia-Pacific

9.5. Rest of the World

9.5.1. Middle East

9.5.2. Africa

9.5.3. Latin America

10. COMPETITIVE LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Cardiovascular Devices Market,

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Cardiovascular Devices Market,

10.7. Key developments and Growth Strategies

10.7.1. New Device Type Launch/Application Deployment

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2022

10.8.2. Major Players R&D Expenditure. 2022

11. COMPANY PROFILES

11.1. B Braun Melsungen AG.

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Device Types Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Abbott

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Device Types Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Johnson & Johnson Services, Inc.

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Device Types Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Medtronic

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Device Types Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Boston Scientific Corporation

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Device Types Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. LIVANOVA PLC.

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Device Types Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Edwards Lifesciences Corporation

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Device Types Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. GE Healthcare

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Device Types Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Siemens Healthcare GmbH

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Device Types Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Terumo Cardiovascular Systems Corporation

11.10.1. Company Overview

11.10.2. Financial Overview

11.10.3. Device Types Offered

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL CARDIOVASCULAR DEVICES MARKET, SYNOPSIS, 2018-2032

TABLE 2 GLOBAL CARDIOVASCULAR DEVICES MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)

TABLE 3 GLOBAL CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 4 GLOBAL CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 5 GLOBAL CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 6 NORTH AMERICA CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 7 NORTH AMERICA CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 8 NORTH AMERICA CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 9 NORTH AMERICA CARDIOVASCULAR DEVICES MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 10 U.S. CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 11 U.S. CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 12 U.S. CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 13 CANADA CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 14 CANADA CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 15 CANADA CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 16 EUROPE CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 17 EUROPE CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 18 EUROPE CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 19 EUROPE CARDIOVASCULAR DEVICES MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 20 GERMANY CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 21 GERMANY CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 22 GERMANY CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 23 FRANCE CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 24 FRANCE CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 25 FRANCE CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 26 ITALY CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 27 ITALY CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 28 ITALY CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 29 SPAIN CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 30 SPAIN CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 31 SPAIN CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 32 U.K CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 33 U.K CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 34 U.K CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 35 REST OF EUROPE CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 36 REST OF EUROPE CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 37 REST OF EUROPE CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 38 ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 39 ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 40 ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 41 ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 42 JAPAN CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 43 JAPAN CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 44 JAPAN CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 45 CHINA CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 46 CHINA CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 47 CHINA CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 48 INDIA CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 49 INDIA CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 50 INDIA CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 51 AUSTRALIA CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 52 AUSTRALIA CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 53 AUSTRALIA CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 54 SOUTH KOREA CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 55 SOUTH KOREA CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 56 SOUTH KOREA CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 57 REST OF ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 58 REST OF ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 59 REST OF ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 60 REST OF WORLD CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 61 REST OF WORLD CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 62 REST OF WORLD CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 63 REST OF WORLD CARDIOVASCULAR DEVICES MARKET, BY COUNTRY, 2018-2032 (USD BILLION)

TABLE 64 MIDDLE EAST CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 65 MIDDLE EAST CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 66 MIDDLE EAST CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 67 AFRICA CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 68 AFRICA CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 69 AFRICA CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION)

TABLE 70 LATIN AMERICA CARDIOVASCULAR DEVICES MARKET, BY DEVICE TYPE, 2018-2032 (USD BILLION)

TABLE 71 LATIN AMERICA CARDIOVASCULAR DEVICES MARKET, BY APPLICATION, 2018-2032 (USD BILLION)

TABLE 72 LATIN AMERICA CARDIOVASCULAR DEVICES MARKET, BY END USER, 2018-2032 (USD BILLION) 

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL CARDIOVASCULAR DEVICES MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL CARDIOVASCULAR DEVICES MARKET

FIGURE 4 GLOBAL CARDIOVASCULAR DEVICES MARKET, SHARE (%), BY DEVICE TYPE, 2022

FIGURE 5 GLOBAL CARDIOVASCULAR DEVICES MARKET, SHARE (%), BY APPLICATION, 2022

FIGURE 6 GLOBAL CARDIOVASCULAR DEVICES MARKET, SHARE (%), BY END USER, 2022

FIGURE 7 GLOBAL CARDIOVASCULAR DEVICES MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 NORTH AMERICA: CARDIOVASCULAR DEVICES MARKET, SHARE (%), BY REGION, 2022

FIGURE 9 EUROPE: CARDIOVASCULAR DEVICES MARKET, SHARE (%), BY REGION, 2022

FIGURE 10 ASIA-PACIFIC: CARDIOVASCULAR DEVICES MARKET, SHARE (%), BY REGION, 2022

FIGURE 11 REST OF THE WORLD: CARDIOVASCULAR DEVICES MARKET, SHARE (%), BY REGION, 2022

FIGURE 12 GLOBAL CARDIOVASCULAR DEVICES MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 13 B BRAUN MELSUNGEN AG.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 B BRAUN MELSUNGEN AG.: SWOT ANALYSIS

FIGURE 15 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 ABBOTT: SWOT ANALYSIS

FIGURE 17 JOHNSON & JOHNSON SERVICES, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 JOHNSON & JOHNSON SERVICES, INC.: SWOT ANALYSIS

FIGURE 19 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 MEDTRONIC: SWOT ANALYSIS

FIGURE 21 BOSTON SCIENTIFIC CORPORATION.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 BOSTON SCIENTIFIC CORPORATION.: SWOT ANALYSIS

FIGURE 23 LIVANOVA PLC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 LIVANOVA PLC.: SWOT ANALYSIS

FIGURE 25 EDWARDS LIFESCIENCES CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 EDWARDS LIFESCIENCES CORPORATION: SWOT ANALYSIS

FIGURE 27 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 GE HEALTHCARE: SWOT ANALYSIS

FIGURE 29 SIEMENS HEALTHCARE GMBH: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 SIEMENS HEALTHCARE GMBH: SWOT ANALYSIS

FIGURE 31 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: SWOT ANALYSIS